Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018
01 Agosto 2018 - 5:05PM
Novavax, Inc. (Nasdaq:NVAX) today announced it will report its
second quarter 2018 financial and operating results following the
close of U.S. financial markets on Wednesday, August 8, 2018.
Conference call details are as follows:
Date: |
August 8,
2018 |
Time: |
4:30 p.m.
U.S. Eastern Time (ET) |
Dial-in
number: |
(877)
212-6076 (Domestic) or (707) 287-9331 (International) |
Passcode: |
5886748 |
Webcast: |
www.novavax.com, “Investors”/ “Events” |
|
Conference call and webcast replay: |
|
|
Dates: |
Starting at
7:30 p.m. ET, August 8, 2018 until 7:30 p.m. ET August 15,
2018 |
Dial-in
number: |
(855)
859-2056 (Domestic) or (404) 537-3406 (International) |
Passcode:
|
5886748 |
Webcast:
|
www.novavax.com, “Investors”/ “Events”, until November 8, 2018 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage
biotechnology company committed to delivering novel products to
prevent infectious diseases. It’s RSV and influenza nanoparticle
vaccine candidates are Novavax’ most advanced clinical programs and
are at the forefront of Novavax’ efforts to improve global health.
For more information, please visit www.novavax.com.
Contact:
InvestorsErika TrahanSenior Manager, Investor & Public
Relationsir@novavax.com240-268-2000
Westwicke PartnersJohn
Woolfordjohn.woolford@westwicke.com 443-213-0506
MediaSam BrownMike
Beyer mikebeyer@sambrown.com 312-961-2502
Novavax (NASDAQ:NVAX)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Novavax (NASDAQ:NVAX)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024